BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30918147)

  • 1. Epidemiologic Trends and Clinical Features of Pneumocystis jirovecii Pneumonia in Non-HIV Patients in a Tertiary-Care Hospital in Korea over a 15-Year-Period.
    Lee HY; Choi SH; Kim T; Chang J; Kim SH; Lee SO; Kim MN; Sung H
    Jpn J Infect Dis; 2019 Jul; 72(4):270-273. PubMed ID: 30918147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway.
    Grønseth S; Rogne T; Hannula R; Åsvold BO; Afset JE; Damås JK
    BMC Infect Dis; 2021 Jul; 21(1):659. PubMed ID: 34233631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of hospital-onset Pneumocystis pneumonia and genotypes of Pneumocystis jirovecii in a single tertiary centre in Korea.
    Kim T; Lee SO; Hong HL; Lee JY; Kim SH; Choi SH; Kim MN; Kim YS; Woo JH; Sung H
    BMC Infect Dis; 2015 Feb; 15():102. PubMed ID: 25884420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV patients: A report of two cases and literature review.
    Markantonatou AM; Ioakimidou A; Arvaniti K; Manou E; Papadopoulos V; Kiriklidou P; Samaras K; Kioumi A; Vyzantiadis TA
    Mycoses; 2017 Oct; 60(10):626-633. PubMed ID: 28660636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of positive
    Lee HY; Kang HS; Lee HY; Rhee CK; Lee SY; Kim SC; Kim SJ; Park YJ; Kim YK; Kang JY
    Korean J Intern Med; 2017 May; 32(3):478-485. PubMed ID: 27951623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction in patients without human immunodeficiency virus infection.
    Hardak E; Neuberger A; Yigla M; Berger G; Finkelstein R; Sprecher H; Oren I
    Respirology; 2012 May; 17(4):681-6. PubMed ID: 22390188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection.
    Su YS; Lu JJ; Perng CL; Chang FY
    J Microbiol Immunol Infect; 2008 Dec; 41(6):478-82. PubMed ID: 19255691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumocystis pneumonia--a retrospective study 1991-2001 in Gothenburg, Sweden.
    Mikaelsson L; Jacobsson G; Andersson R
    J Infect; 2006 Oct; 53(4):260-5. PubMed ID: 16403575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome and predictors of survival in patients with pneumocystis jirovecii pneumonia--results of a tertiary referral centre.
    Roembke F; Heinzow HS; Gosseling T; Heinecke A; Domagk D; Domschke W; Meister T
    Clin Respir J; 2014 Jan; 8(1):86-92. PubMed ID: 23848504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predisposing factors, clinical characteristics and outcome of Pneumonocystis jirovecii pneumonia in HIV-negative patients.
    Kofteridis DP; Valachis A; Velegraki M; Antoniou M; Christofaki M; Vrentzos GE; Andrianaki AM; Samonis G
    J Infect Chemother; 2014 Jul; 20(7):412-6. PubMed ID: 24767467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiquantitative Real-Time PCR to Distinguish Pneumocystis Pneumonia from Colonization in a Heterogeneous Population of HIV-Negative Immunocompromised Patients.
    Grønseth S; Rogne T; Hannula R; Åsvold BO; Afset JE; Damås JK
    Microbiol Spectr; 2021 Sep; 9(1):e0002621. PubMed ID: 34346746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness.
    Kim TO; Lee JK; Kwon YS; Kim YI; Lim SC; Kim MS; Kho BG; Park CK; Oh IJ; Kim YC; Park HY; Shin HJ
    PLoS One; 2021; 16(2):e0246296. PubMed ID: 33539407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection.
    Kim SJ; Lee J; Cho YJ; Park YS; Lee CH; Yoon HI; Lee SM; Yim JJ; Lee JH; Yoo CG; Lee CT; Kim YW; Han SK; Kim HB; Park JS
    J Infect; 2014 Jul; 69(1):88-95. PubMed ID: 24607411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and mortality in immunocompromised non-HIV patients.
    Korkmaz Ekren P; Töreyin ZN; Nahid P; Doskaya M; Caner A; Turgay N; Zeytinoglu A; Toz S; Bacakoglu F; Guruz Y; Erensoy S
    Clin Respir J; 2018 Nov; 12(11):2590-2597. PubMed ID: 30244544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis jirovecii pneumonia (PCP) PCR-negative conversion predicts prognosis of HIV-negative patients with PCP and acute respiratory failure.
    Choi JS; Lee SH; Leem AY; Song JH; Kim SY; Chung KS; Jung JY; Kang YA; Kim YS; Chang J; Park MS
    PLoS One; 2018; 13(10):e0206231. PubMed ID: 30359436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years.
    Schmidt JJ; Lueck C; Ziesing S; Stoll M; Haller H; Gottlieb J; Eder M; Welte T; Hoeper MM; Scherag A; David S
    Crit Care; 2018 Nov; 22(1):307. PubMed ID: 30454031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Pneumocystis jirovecii pneumonia (2010-2013): the first Croatian report.
    Babic-Erceg A; Vilibic-Cavlek T; Erceg M; Mlinaric-Missoni E; Begovac J
    Acta Microbiol Immunol Hung; 2014 Jun; 61(2):181-8. PubMed ID: 24939686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons.
    McKinnell JA; Cannella AP; Kunz DF; Hook EW; Moser SA; Miller LG; Baddley JW; Pappas PG
    Transpl Infect Dis; 2012 Oct; 14(5):510-8. PubMed ID: 22548840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies.
    Tasaka S; Tokuda H
    J Infect Chemother; 2012 Dec; 18(6):793-806. PubMed ID: 22864454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.
    Salzer HJF; Schäfer G; Hoenigl M; Günther G; Hoffmann C; Kalsdorf B; Alanio A; Lange C
    Respiration; 2018; 96(1):52-65. PubMed ID: 29635251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.